Lifemd Inc (LFMDP)

$22.37

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $22.12
    $22.37
    $22.37
    downward going graph

    1.1%

    Downside

    Day's Volatility :1.1%

    Upside

    0.0%

    downward going graph
  • $14.95
    $23.74
    $22.37
    downward going graph

    33.17%

    Downside

    52 Weeks Volatility :37.03%

    Upside

    5.77%

    downward going graph

Returns

PeriodLifemd IncIndex (Russel 2000)
3 Months
-0.28%
0.0%
6 Months
21.96%
0.0%
1 Year
21.23%
0.0%
3 Years
-7.57%
-19.4%

Highlights

Book Value
- $0.02
Dividend Share
0.0
Dividend Yield
9.92%
Earnings Per Share (EPS)
-2.26
Profit Margin
-14.28%
Operating Margin TTM
-13.98%
Return On Assets TTM
-23.35%
Return On Equity TTM
-782.48%
Revenue TTM
163.6M
Revenue Per Share TTM
4.57
Quarterly Revenue Growth YOY
33.300000000000004%
Gross Profit TTM
100.4M
EBITDA
-16.6M
Diluted Eps TTM
-2.256
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    90%Buy
    9%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Lifemd Inc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
00
00
00

Company Financials

FY18Y/Y Change
Revenue
8.3M
↑ 64.68%
Net Income
-1.2M
↑ 2.89%
Net Profit Margin
-14.91%
↑ 8.95%
FY19Y/Y Change
Revenue
12.5M
↑ 49.79%
Net Income
-3.5M
↑ 184.35%
Net Profit Margin
-28.3%
↓ 13.39%
FY20Y/Y Change
Revenue
37.3M
↑ 199.1%
Net Income
-60.5M
↑ 1615.42%
Net Profit Margin
-162.29%
↓ 133.99%
FY21Y/Y Change
Revenue
92.9M
↑ 149.04%
Net Income
-61.3M
↑ 1.32%
Net Profit Margin
-66.03%
↑ 96.26%
FY22Y/Y Change
Revenue
119.0M
↑ 28.16%
Net Income
-45.0M
↓ 26.59%
Net Profit Margin
-37.82%
↑ 28.21%
FY23Y/Y Change
Revenue
152.5M
↑ 28.15%
Net Income
-20.6M
↓ 54.25%
Net Profit Margin
-13.5%
↑ 24.32%
Q4 FY22Q/Q Change
Revenue
28.1M
↓ 10.48%
Net Income
-11.6M
↑ 37.17%
Net Profit Margin
-41.16%
↓ 14.3%
Q1 FY23Q/Q Change
Revenue
33.1M
↑ 17.8%
Net Income
-10.1M
↓ 12.89%
Net Profit Margin
-30.44%
↑ 10.72%
Q2 FY23Q/Q Change
Revenue
35.9M
↑ 8.51%
Net Income
-6.7M
↓ 33.22%
Net Profit Margin
-18.73%
↑ 11.71%
Q3 FY23Q/Q Change
Revenue
38.6M
↑ 7.42%
Net Income
-6.1M
↓ 9.07%
Net Profit Margin
-15.86%
↑ 2.87%
Q4 FY23Q/Q Change
Revenue
44.9M
↑ 16.18%
Net Income
-3.7M
↓ 39.04%
Net Profit Margin
-8.32%
↑ 7.54%
Q1 FY24Q/Q Change
Revenue
44.1M
↓ 1.6%
Net Income
-6.8M
↑ 81.36%
Net Profit Margin
-15.33%
↓ 7.01%
FY18Y/Y Change
Total Assets
2.6M
↑ 107.0%
Total Liabilities
1.8M
↑ 180.26%
FY19Y/Y Change
Total Assets
3.4M
↑ 31.73%
Total Liabilities
4.6M
↑ 154.7%
FY20Y/Y Change
Total Assets
13.1M
↑ 278.79%
Total Liabilities
13.9M
↑ 203.26%
FY21Y/Y Change
Total Assets
49.9M
↑ 282.45%
Total Liabilities
24.1M
↑ 73.72%
FY22Y/Y Change
Total Assets
25.7M
↓ 48.59%
Total Liabilities
33.0M
↑ 36.79%
FY23Y/Y Change
Total Assets
58.5M
↑ 127.85%
Total Liabilities
52.9M
↑ 60.49%
Q4 FY22Q/Q Change
Total Assets
25.7M
↓ 23.07%
Total Liabilities
33.0M
↑ 8.89%
Q1 FY23Q/Q Change
Total Assets
33.9M
↑ 31.96%
Total Liabilities
41.2M
↑ 25.05%
Q2 FY23Q/Q Change
Total Assets
35.4M
↑ 4.65%
Total Liabilities
45.7M
↑ 10.72%
Q3 FY23Q/Q Change
Total Assets
40.7M
↑ 14.8%
Total Liabilities
51.8M
↑ 13.41%
Q4 FY23Q/Q Change
Total Assets
58.5M
↑ 43.72%
Total Liabilities
52.9M
↑ 2.2%
Q1 FY24Q/Q Change
Total Assets
61.5M
↑ 5.09%
Total Liabilities
60.2M
↑ 13.69%
FY18Y/Y Change
Operating Cash Flow
-905.5K
↑ 10.81%
Investing Cash Flow
141.4K
↑ 0.0%
Financing Cash Flow
802.8K
↑ 3.45%
FY19Y/Y Change
Operating Cash Flow
251.4K
↓ 127.76%
Investing Cash Flow
-100.0K
↓ 170.7%
Financing Cash Flow
775.1K
↓ 3.45%
FY20Y/Y Change
Operating Cash Flow
-12.1M
↓ 4925.47%
Investing Cash Flow
-798.1K
↑ 698.14%
Financing Cash Flow
21.0M
↑ 2609.53%
FY21Y/Y Change
Operating Cash Flow
-33.1M
↑ 172.72%
Investing Cash Flow
-3.4M
↑ 326.28%
Financing Cash Flow
68.6M
↑ 226.81%
FY22Y/Y Change
Operating Cash Flow
-22.9M
↓ 30.68%
Investing Cash Flow
-13.9M
↑ 308.72%
Financing Cash Flow
-528.2K
↓ 100.77%
Q4 FY22Q/Q Change
Operating Cash Flow
-2.0M
↓ 29.07%
Investing Cash Flow
-1.8M
↓ 20.99%
Financing Cash Flow
1.9M
↓ 315.8%
Q1 FY23Q/Q Change
Operating Cash Flow
-2.6M
↑ 32.75%
Investing Cash Flow
-2.3M
↑ 29.94%
Financing Cash Flow
12.0M
↑ 543.94%
Q2 FY23Q/Q Change
Operating Cash Flow
4.6M
↓ 277.68%
Investing Cash Flow
-2.3M
↑ 0.0%
Financing Cash Flow
-2.0M
↓ 116.35%

Technicals Summary

Sell

Neutral

Buy

Lifemd Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lifemd Inc
Lifemd Inc
-1.68%
21.96%
21.23%
-7.57%
-7.57%
Solventum Corp
Solventum Corp
1.49%
-20.98%
-20.98%
-20.98%
-20.98%
Veeva Systems Inc.
Veeva Systems Inc.
-0.3%
-12.48%
-7.86%
-43.43%
8.57%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
1.26%
7.77%
-1.72%
32.98%
32.98%
Healthequity Inc
Healthequity Inc
-10.8%
-2.08%
15.7%
-2.16%
-8.24%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lifemd Inc
Lifemd Inc
NA
NA
NA
0.0
-7.82
-0.23
0.1
-0.02
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
53.22
53.22
1.35
4.76
0.13
0.06
NA
30.25
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
23.38
23.38
20.11
4.27
0.22
0.06
0.0
16.23
Healthequity Inc
Healthequity Inc
84.29
84.29
2.29
2.19
0.04
0.03
NA
24.11
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lifemd Inc
Lifemd Inc
Buy
$273.5M
-7.57%
NA
-14.28%
Solventum Corp
Solventum Corp
Hold
$10.8B
-20.98%
NA
15.73%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$29.2B
8.57%
53.22
22.34%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$36.7B
32.98%
23.38
8.05%
Healthequity Inc
Healthequity Inc
Buy
$6.7B
-8.24%
84.29
7.71%

Insights on Lifemd Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 44.85M → 44.14M (in $), with an average decrease of 1.6% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -3.73M → -6.76M (in $), with an average decrease of 81.4% per quarter

Company Information

lifemd is a comprehensive one-stop telemedicine/telehealth solution with a platform that provides a fully integrated telehealth solution to connect physicians, medical providers, pharmacists, and patients worldwide. the platform is hipaa-compliant and all interactions and communication between physicians, healthcare providers and patients are aes-encrypted. the platform allows physicians, healthcare providers and patients to securely connect and manage common medical conditions. lifemd also custom fabricates mobile diagnostic telehealth equipment such as cases, carts and kiosks. the service is available 24/7/365.

Organization
Lifemd Inc
Employees
207
CEO
Mr. Justin Schreiber
Industry
Miscellaneous

FAQs